JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has entered into a settlement agreement with an institution that acted as a broker in placing investments in Teva’s portfolio of auction rate securities. In consideration for a full release of the institution, Teva has received a cash payment of $100 million. Due to confidentially restrictions, additional information will not be disclosed.
